Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCLKallesh D. Jayappa, Michael J. Weber, Stefan Bekiranov et al.|Blood Advances|2017Cited by 116
Extrinsic Factors in the In Vivo Macroenvironment Generate Phenotypic Resistance to BTK/Bcl-2 Targeted Therapies in Chronic Lymphocytic Leukemia and Mantle Cell LymphomaKallesh D. Jayappa, Michael J. Weber, Craig A. Portell et al.|Blood|2016Cited by 0